Eyenovia Inc (EYEN)
0.7499
-0.07
(-8.65%)
USD |
NASDAQ |
May 17, 16:00
0.7499
0.00 (0.00%)
After-Hours: 20:00
Eyenovia Enterprise Value: 47.34M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 47.34M |
| May 16, 2024 | 51.16M |
| May 15, 2024 | 64.04M |
| May 14, 2024 | 51.45M |
| May 13, 2024 | 50.88M |
| May 10, 2024 | 48.49M |
| May 09, 2024 | 47.94M |
| May 08, 2024 | 51.02M |
| May 07, 2024 | 48.44M |
| May 06, 2024 | 51.50M |
| May 03, 2024 | 58.41M |
| May 02, 2024 | 54.71M |
| May 01, 2024 | 53.56M |
| April 30, 2024 | 45.21M |
| April 29, 2024 | 43.23M |
| April 26, 2024 | 38.95M |
| April 25, 2024 | 43.18M |
| April 24, 2024 | 36.67M |
| April 23, 2024 | 34.59M |
| April 22, 2024 | 33.26M |
| April 19, 2024 | 36.01M |
| April 18, 2024 | 33.99M |
| April 17, 2024 | 34.42M |
| April 16, 2024 | 35.14M |
| April 15, 2024 | 32.99M |
| Date | Value |
|---|---|
| April 12, 2024 | 32.05M |
| April 11, 2024 | 34.99M |
| April 10, 2024 | 32.69M |
| April 09, 2024 | 36.09M |
| April 08, 2024 | 41.53M |
| April 05, 2024 | 49.11M |
| April 04, 2024 | 49.27M |
| April 03, 2024 | 49.60M |
| April 02, 2024 | 52.63M |
| April 01, 2024 | 53.54M |
| March 31, 2024 | 53.66M |
| March 28, 2024 | 46.16M |
| March 27, 2024 | 46.18M |
| March 26, 2024 | 47.30M |
| March 25, 2024 | 55.35M |
| March 22, 2024 | 53.46M |
| March 21, 2024 | 55.35M |
| March 20, 2024 | 57.25M |
| March 19, 2024 | 55.12M |
| March 18, 2024 | 71.94M |
| March 15, 2024 | 74.78M |
| March 14, 2024 | 72.78M |
| March 13, 2024 | 76.88M |
| March 12, 2024 | 74.60M |
| March 11, 2024 | 71.41M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
16.12M
Minimum
Mar 18 2020
209.38M
Maximum
May 03 2023
74.13M
Average
67.28M
Median
Oct 28 2022
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 5.156M |
| Alpine Immune Sciences Inc | 4.151B |
| Lantern Pharma Inc | 26.52M |
| Oragenics Inc | 8.862M |
| MAIA Biotechnology Inc | 64.01M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.92M |
| Revenue (Quarterly) | 0.005M |
| Total Expenses (Quarterly) | 10.07M |
| EPS Diluted (Quarterly) | -0.23 |
| Profit Margin (Quarterly) | -218.7K% |
| Earnings Yield | -97.35% |
| Normalized Earnings Yield | -96.78 |